|
F11R expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.724190E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.240400E-02 |
| Normal-vs-Stage2 |
4.514200E-01 |
| Normal-vs-Stage3 |
4.503400E-01 |
| Normal-vs-Stage4 |
3.280400E-01 |
| Stage1-vs-Stage2 |
4.923700E-02 |
| Stage1-vs-Stage3 |
3.596200E-01 |
| Stage1-vs-Stage4 |
6.726800E-01 |
| Stage2-vs-Stage3 |
1.671000E-01 |
| Stage2-vs-Stage4 |
1.428630E-01 |
| Stage3-vs-Stage4 |
7.586800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.405600E-02 |
| Normal-vs-AfricanAmerican |
8.374100E-02 |
| Normal-vs-Asian |
1.260970E-01 |
| Caucasian-vs-AfricanAmerican |
3.672600E-01 |
| Caucasian-vs-Asian |
6.777800E-01 |
| AfricanAmerican-vs-Asian |
6.106000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.725800E-01 |
| Normal-vs-Female |
1.586790E-01 |
| Male-vs-Female |
7.026400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.711680E-02 |
| Normal-vs-Age(41-60Yrs) |
3.975000E-01 |
| Normal-vs-Age(61-80Yrs) |
7.527800E-01 |
| Normal-vs-Age(81-100Yrs) |
7.060600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.478200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.244500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.319900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.483200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.540600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.922000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.357600E-03 |
| Classical-VS-Follicular |
1.55431223447522E-15 |
| Classical-VS-Other |
2.902200E-01 |
| Classical-VS-Normal |
5.392100E-04 |
| Tall-VS-Follicular |
1.371710E-04 |
| Tall-VS-Other |
9.951000E-01 |
| Tall-VS-Normal |
8.990000E-01 |
| Follicular-VS-Other |
9.479800E-02 |
| Follicular-VS-Normal |
8.39930000000599E-05 |
| Other-VS-Normal |
9.584600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.693800E-01 |
| Normal-vs-N1 |
4.266600E-01 |
| N0-vs-N1 |
3.105400E-01 |
|
|
